Australia has contracted 20 million imported Pfizer doses, which is the preferred option for adults under 50 years old because of the blood clotting risks associated with the AstraZeneca shot. The government also has deals for 3.8 million imported AstraZeneca doses plus 50 million locally manufactured doses.